Assignee
DEBRECENI EGYETEM
HU·4 granted patents·11 pending applications·3 citations·filing 2006–2023
Top patents by PatentIndex Score
15 records- 0175US10568976B23,6,9, 15-tetraaza-bicyclo [9.3.1 ]pentadeca-1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agentsDEBRECENI EGYETEM·Filed 2016·Granted Feb 25, 2020·2 cites·15 claims
- 0267US10494379B26-oxa-3,9,15-triaza-bicyclo[9.3.1]pentadeca-1(14),11(15),12-triene derivatives based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agentsDEBRECENI EGYETEM·Filed 2016·Granted Dec 3, 2019·1 cites·20 claims
- 0365US2025325621A1Complex extract of sour cherry and process for the preparation of such extractDEBRECENI EGYETEM·Filed 2023·Application pending·0 cites
- 0458US2025163088A1Half-sandwich transition metal complexes and uses thereofDEBRECENI EGYETEM·Filed 2022·Application pending·0 cites
- 0558US2009238903A1Process for the preparation of sour cherry seed extract, use of the extract for the preparation of pharmaceutical compositions and pharmaceutical compositions containing said extractDEBRECENI EGYETEM·Filed 2006·Application pending·0 cites
- 0651US10894096B23,6,9, 15-tetraaza-bicyclo [9.3.1]pentadeca-1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agentsDEBRECENI EGYETEM·Filed 2020·Granted Jan 19, 2021·0 cites·16 claims
- 0749US10968224B22,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based MRI contrast agents and 52MN based PET contrast agentsDEBRECENI EGYETEM·Filed 2016·Granted Apr 6, 2021·0 cites·6 claims
- 0848US2011129553A1Process for the preparation of sour cherry seed extract, use of the extract for the preparation of pharmaceutical compositions and pharmaceutical compositions containing said extractDEBRECENI EGYETEM·Filed 2011·Application pending·0 cites
- 0945US2025171490A1Dhea-derived steroidsDEBRECENI EGYETEM·Filed 2023·Application pending·0 cites
- 1044US2023048678A1Ican derivatives for antifungal useDEBRECENI EGYETEM·Filed 2020·Application pending·0 cites
- 1143US2016303554A1Catalyst, hydrogenation of hydrogen carbonate, hydrogen storage systemDEBRECENI EGYETEM·Filed 2014·Application pending·0 cites
- 1239US2015115705A1Circuit arrangement and a method for controlling an ac drive system of an electric vehicleDEBRECENI EGYETEM·Filed 2013·Application pending·0 cites
- 1335US2013117572A1Portable electronic device, system and method for authenticating a document associated with a geographical locationDEBRECENI EGYETEM·Filed 2012·Application pending·0 cites
- 1434US2010068745A1Process and kit for measuring the condition of the fibrinolitic systemDEBRECENI EGYETEM·Filed 2009·Application pending·0 cites
- 1533US2014323589A1Method for the preparation of composite silica alcogels, aerogels and xerogels, apparatus for carrying out the method continuously, and novel composite silica alcogels, aerogels and xerogelsDEBRECENI EGYETEM·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DEBRECENI EGYETEM files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →